Documented in Peer-Reviewed Research

CJC-1295

GHRH Analogue

CJC-1295 is a synthetic 30-amino acid peptide analogue of growth hormone-releasing hormone (GHRH). Modified for enhanced stability, it activates pituitary GHRH receptors to stimulate pulsatile growth hormone release.

GHRH Receptor Agonism
Pulsatile GH Release
Extended Half-Life
Pituitary Activation

Appears in: Compounds studied in growth-hormone-axis research

Quantified findings reported in the literature

amino acid residues in the CJC-1295 peptide sequence

Teichman et al., J Clin Endocrinol Metab 2006

96-99%

HPLC-verified purity range across published batch testing

Stemcode Peptides COA data

Published, peer-reviewed studies

J Clin Endocrinol Metab2006
Prolonged stimulation of growth hormone secretion by CJC-1295
Clinical study demonstrating CJC-1295's ability to produce sustained, dose-dependent increases in growth hormone and IGF-1 levels.
View source on PubMed/DOI ↗
Endocrine2008
Growth hormone-releasing hormone analogues: chemistry and pharmacology
View source on PubMed/DOI ↗

Third-party analytical reports

Certificates of Analysis from independent laboratories for products supplied by Stemcode. Reported values describe the analysed material; they are reported as documented and are distinct from the published literature above.

CJC-1295Qalitex

Net content: 5.2 mg/bottle
Lot: SP26-CJN05
COA #: COA-2026-9149600
Report date: 07/17/2026

View full report ↗

Stemcode supplies CJC-1295 as a research-grade compound for laboratory research use only — not for human or animal consumption.

View the research-grade product →